Crossmark

Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on B cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma

Crossref DOI link: https://doi.org/10.1007/s00262-022-03143-2

Published Online: 2022-02-13

Published Print: 2022-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Song, Peng

Li, Wenbin

Wu, Xiaoxuan

Qian, Zhirong

Ying, Jianming

Gao, Shugeng

He, Jie https://orcid.org/0000-0002-0285-5403
Funding

Funding for this research was provided by:

National Key R&D Program of China (2020AAA0109500)

R&D Program of Beijing Municipal Education commission (KJZD20191002302)

Beijing Municipal Science & Technology Commission (Z191100006619119)

Beijing Hope Run Special Fund of Cancer Foundation of China (LC2019A11)

Beijing Nova Program of Science and Technology (Z191100001119095)

The Institutional Fundamental Research Funds (2018PT32033)
License Information

Text and Data Mining valid from 2022-02-13

Version of Record valid from 2022-02-13
More Information

Article History

Received: 6 October 2021

Accepted: 27 December 2021

First Online: 13 February 2022

Declarations

:

: The authors declare no competing interests.

: All the analyzed data used in our research were collected from a public database, such as TCGA and GEO; therefore, informed consent was not required for this analysis.

: Since this was a retrospective study and all the data used in our study were obtained from public databases TCGA and GEO, therefore, ethical approval was not required.

Document is current

Any future updates will be listed below